Herbert Smith Freehills advised SF Holding on the deal, while Clifford Chance advised the underwriters. S.F. Holding Co., Ltd. completed its global offering and listing on...
S.F. Holding’s $750 Million IPO On HKSE
TS Lines’ IPO on Hong Kong Stock Exchange
Herbert Smith Freehills advised joint sponsors on T.S. Lines’ Hong Kong IPO. T.S. Lines Limited (02510.HK) completed its listing on the Main Board of the Hong...
MMG’s HK$9bn Rights Issue
Herbert Smith Freehills advised MMG on rights issue. MMG Limited (01208.HK) successfully completed a HK$9 billion rights issue, marking one of the largest equity fundraising efforts...
China Huaneng Group’s $500m Issuance in 5.30% Perpetual Bonds
Herbert Smith Freehills advised China Huaneng Group on US$500 million perpetual bond offering. China Huaneng Group Co., Ltd successfully issued US$500 million in 5.30% subordinated guaranteed...
Cutia Therapeutics’ IPO on Hong Kong Market
Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on the listing. Cutia Therapeutics, a company with operations in Beijing, Hong Kong, Shanghai,...
MedSci Healthcare Holdings Limited’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie Capital Limited. MedSci Healthcare operates one of the largest online professional...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
Hangzhou GreatStar Industrial Co., Ltd.’s Listing on the SIX Swiss Exchange
Clifford Chance, Niederer Kraft Frey, Vischer and T&C Law Firm advised Hangzhou GreatStar Industrial Co., Ltd. on the deal. Allen & Overy advised the sole global...
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Onewo’s US$738 Million Hong Kong IPO
Paul Hastings and JunHe advised Onewo Inc. on the deal. Herbert Smith Freehills advised CITIC Securities, Citigroup and Goldman Sachs as joint sponsors. Onewo Inc. announced its approximately...
Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...